MyFinsight
Home
Blog
About
Short-term investments
$94,365,000
(4568.45%↑ Y/Y)
Cash and cash
equivalents
$8,267,000
(123.90%↑ Y/Y)
Prepaid expenses and
other current assets
$3,461,000
(-3.72%↓ Y/Y)
Accrued interest
receivable
$1,844,000
Total property, plant
and equipment,...
$32,981,000
(10.18%↑ Y/Y)
Total current assets
$107,937,000
(1059.60%↑ Y/Y)
Long-term investments
$105,346,000
Property, plant and
equipment, net
$14,229,000
(2.68%↑ Y/Y)
Long-term prepaid assets
$5,344,000
(3317.29%↑ Y/Y)
Financing lease
right-of-use assets
$3,453,000
(-2.44%↓ Y/Y)
Operating lease
right-of-use assets
$1,901,000
(-36.77%↓ Y/Y)
Less accumulated
depreciation and...
$18,752,000
(16.64%↑ Y/Y)
Total assets
$238,210,000
(690.62%↑ Y/Y)
Total liabilities and
stockholders' equity
$238,210,000
(690.62%↑ Y/Y)
Total stockholders'
equity
$214,785,000
(1687.46%↑ Y/Y)
Total liabilities
$23,425,000
(29.33%↑ Y/Y)
Accumulated deficit
-$152,255,000
(-9.16%↓ Y/Y)
Treasury stock, at cost
54,665 shares held at...
$5,521,000
(-0.00%↓ Y/Y)
Accumulated other
comprehensive income (loss)
-$930,000
(-5784.21%↓ Y/Y)
Additional paid-in capital
$373,483,000
(137.84%↑ Y/Y)
Total current
liabilities
$11,705,000
(9.62%↑ Y/Y)
Warrant liabilities
$7,229,000
(265.01%↑ Y/Y)
Finance lease
liabilities, noncurrent
$3,040,000
(-5.01%↓ Y/Y)
Operating lease
liabilities, noncurrent
$1,451,000
(-35.65%↓ Y/Y)
Common stock 0.0001 par
value 800,000,000...
$8,000
(754.70%↑ Y/Y)
Accrued expenses and
other current...
$7,209,000
(1.65%↑ Y/Y)
Accounts payable
$3,855,000
(47.01%↑ Y/Y)
Operating lease
liabilities, current portion
$481,000
(-40.99%↓ Y/Y)
Finance lease
liabilities, current portion
$160,000
(7.99%↑ Y/Y)
Back
Back
Balance Sheet
SAB Biotherapeutics, Inc. (SABS)
SAB Biotherapeutics, Inc. (SABS)
source: myfinsight.com